Anti-dsDNA antibodies from SLE patients can activate NLRP3 inflammasome in monocytes/macrophages by binding to TLR4 and activating TLR4-NF-κB signal pathway. This evidence concerns the gene NFKB1 and systemic lupus erythematosus.